135 related articles for article (PubMed ID: 10773967)
21. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
22. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA
Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
[TBL] [Abstract][Full Text] [Related]
23. Relevance of multidrug resistance 1 and P-glycoprotein to drug resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Tanaka Y
Histol Histopathol; 2007 Apr; 22(4):465-8. PubMed ID: 17290357
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment.
Fardel O; Lecureur V; Daval S; Corlu A; Guillouzo A
Eur J Biochem; 1997 May; 246(1):186-92. PubMed ID: 9210482
[TBL] [Abstract][Full Text] [Related]
25. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M; Turzanski J; Langabeer S; Russell NH
Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
[TBL] [Abstract][Full Text] [Related]
26. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
[TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
[TBL] [Abstract][Full Text] [Related]
28. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
29. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein.
Pétriz J; Gottesman MM; Aran JM
Curr Drug Deliv; 2004 Jan; 1(1):43-56. PubMed ID: 16305369
[TBL] [Abstract][Full Text] [Related]
30. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
31. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
[TBL] [Abstract][Full Text] [Related]
33. [Cyclosporin A reverses steroid-resistance induced by P-glycoprotein in patients with SLE].
Tanaka Y; Awazu Y; Saito K; Fujii K; Ota T; Kohno K; Eto S
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):406-9. PubMed ID: 10726475
[No Abstract] [Full Text] [Related]
34. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
Nielsen D; Maare C; Skovsgaard T
Biochem Pharmacol; 1995 Aug; 50(4):443-50. PubMed ID: 7646548
[TBL] [Abstract][Full Text] [Related]
35. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
[TBL] [Abstract][Full Text] [Related]
36. Fc-gamma receptor expression profile in a North-Indian cohort of pediatric-onset systemic lupus erythematosus: An observational study.
Williams V; Rawat A; Vignesh P; Shandilya JK; Gupta A; Singh S
Int J Rheum Dis; 2019 Mar; 22(3):449-457. PubMed ID: 30399647
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.
Dammacco F; Della Casa Alberighi O; Ferraccioli G; Racanelli V; Casatta L; Bartoli E
Int J Clin Lab Res; 2000; 30(2):67-73. PubMed ID: 11043499
[TBL] [Abstract][Full Text] [Related]
38. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
39. Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells.
Candussio L; Crivellato E; Rosati AM; Klugmann FB; Granzotto M; Giraldi T; Decorti G
Histochem J; 2001 May; 33(5):259-66. PubMed ID: 11563538
[TBL] [Abstract][Full Text] [Related]
40. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]